MyCamper is a European growth champion The Financial Times has included the Basel-based firm MyCamper in its list of the 1,000…martin03.15.2021
BioVersys receives funding in the fight against tuberculosis The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners.…annett03.01.2021
Biosynex takes up residence in Delémont The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a…annett03.01.2021
Novartis Campus opening further Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus.…annett02.25.2021
Hemex attracts Swiss investors A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed…martin02.11.2021
Rhizen drug secures approval in the USA The United States Food and Drug Administration has granted accelerated approval for the drug Umbralisib.…martin02.10.2021
Novaremed secures US$50 million Basel biotech Novaremed is receiving US$50 million through an agreement with an investment group. Novaremed…martin02.03.2021
Axtria driving growth from Basel The US firm Axtria has established a new office in Basel. The company offers services…martin02.01.2021
Technologiepark Basel celebrates its role as a driver of innovation The Technologiepark Basel will be ten years old in 2021. Over the past decade, it…martin01.28.2021
Basel Area has ever more to offer investors The canton of Basel-Stadt has displayed the most striking performance in the Swiss Venture Capital…martin01.28.2021